Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Journal of Tissue Engineering and Regenerative Medicine
|
March 12, 2015
Anterior cruciate ligament- and hamstring tendon-derived cells: in vitro differential properties of cells involved in ACL reconstruction
Corina Adriana Ghebes, Cindy Kelder, Thomas Schot, et al.
Journal of Surgical Oncology
|
May 8, 2000
Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone
A J Renard, R P Veth, H W Schreuder, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)
M van Glabbeke, J Renard, H M Pinedo, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas
R Abele, M Clavel, P Dodion, et al.
European Journal of Cancer
|
July 1, 1979
Dianhydrogalactitol (NSC-132313): phase II study in solid tumors
R de Jager, A Brugarolas, H Hansen, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1986
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group
U Bruntsch, P Dodion, W W Ten Bokkel Huinink, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancer
M Beer, F Cavalli, S B Kaye, et al.
Journal of Biological Response Modifiers
|
June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma
U Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
C Sessa, C Minoia, A Ronchi, et al.
Journal of Surgical Oncology
|
November 24, 1999
Osteosarcoma: oncologic and functional results. A single institutional report covering 22 years
A J Renard, R P Veth, H W Schreuder, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Journal of Tissue Engineering and Regenerative Medicine
|
March 12, 2015
Anterior cruciate ligament- and hamstring tendon-derived cells: in vitro differential properties of cells involved in ACL reconstruction
Corina Adriana Ghebes, Cindy Kelder, Thomas Schot, et al.
Journal of Surgical Oncology
|
May 8, 2000
Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone
A J Renard, R P Veth, H W Schreuder, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1988
Iproplatin and carboplatin induced toxicities: overview of phase II clinical trial conducted by the EORTC Early Clinical Trials Cooperative Group (ECTG)
M van Glabbeke, J Renard, H M Pinedo, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas
R Abele, M Clavel, P Dodion, et al.
European Journal of Cancer
|
July 1, 1979
Dianhydrogalactitol (NSC-132313): phase II study in solid tumors
R de Jager, A Brugarolas, H Hansen, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1986
Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group
U Bruntsch, P Dodion, W W Ten Bokkel Huinink, et al.
European Journal of Cancer & Clinical Oncology
|
October 1, 1987
A phase II study of carboplatin in advanced or metastatic stomach cancer
M Beer, F Cavalli, S B Kaye, et al.
Journal of Biological Response Modifiers
|
June 1, 1990
Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma
U Bruntsch, P H de Mulder, W W ten Bokkel Huinink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
C Sessa, C Minoia, A Ronchi, et al.
Journal of Surgical Oncology
|
November 24, 1999
Osteosarcoma: oncologic and functional results. A single institutional report covering 22 years
A J Renard, R P Veth, H W Schreuder, et al.
Page
of 10